Author name: Gertrud U. Rey

Gertrud Rey (who also goes by Trudy Rey) is a trained virologist who resides in Atlanta, Georgia. She has a PhD in molecular genetics and biochemistry from Georgia State University, where her studies involved the analysis of various aspects of the genetics of West Nile virus and simian hemorrhagic fever virus. After finishing the PhD program in 2007, she accepted a post-doctoral fellowship at the Centers for Disease Control and Prevention, where she continued to study virology in the context of respiratory syncytial virus, with a more pronounced focus on immunology. During that time, she was also a lecturer at Georgia State University, where she designed an undergraduate biology course and supervised teaching assistants at the university’s biology laboratory. In 2012, she decided to retire from bench science and lecturing to pursue a career in patent law. She is now registered as a patent agent at the U.S. Patent and Trademark Office, and works for a major law firm. Her day to day responsibilities include preparing and prosecuting U.S. and international patent applications in the field of molecular and cell biology, virology, biochemistry, genetic engineering, tissue engineering, transgenic biology, stem cell research, immunology, drug delivery, phage therapeutics, and medical devices. However, Trudy still spends much of her free time communicating science, both for virology blog, and for her very own YouTube channel, where she hosts a show about viruses called “Catch This.” You can also find her on X, under the handle “Dr. T.” Trudy was also a guest on TWiV 179 and 424.

Preliminary phase I/II results of ChAdOx1 SARS-CoV-2 vaccine

2 Comments / Basic virology, Gertrud Rey, Information / By

by Gertrud U. Rey On July 20, 2020, Oxford University’s Jenner Institute and the pharmaceutical company AstraZeneca reported preliminary results from phase I/II clinical trials assessing the safety and efficacy of a vaccine candidate against SARS-CoV-2.  The vaccine candidate, named AZD1222 (referred to in the publication as ChAdOx1 nCoV-19), consists of an adenovirus vector with an …

Preliminary phase I/II results of ChAdOx1 SARS-CoV-2 vaccine Read More »

The role of children in transmission of SARS-CoV-2

7 Comments / Basic virology, Gertrud Rey / By

by Gertrud U. Rey It is well established that children experience less severe disease after infection with SARS-CoV-2. However, to what extent infected children contribute to transmission of the virus is less clear. This topic is of great interest as we prepare for the start of a new school year.  Are children less susceptible to infection …

The role of children in transmission of SARS-CoV-2 Read More »

The perfect storm

6 Comments / Basic virology, Gertrud Rey, Information / By

by Gertrud U. Rey A small subset of people are more vulnerable to severe complications and death resulting from SARS-CoV-2 infection. What causes this vulnerability? An increasing body of evidence suggests that patients suffering from severe COVID-19 often have one or more pre-existing conditions (co-morbidities). In an effort to describe the co-morbidities of COVID-19 patients …

The perfect storm Read More »

Scroll to Top